Rani Therapeutics
RANI
RANI
34 hedge funds and large institutions have $11.8M invested in Rani Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
1.44% less ownership
Funds ownership: 13.26% → 11.82% (-1.4%)
8% less funds holding
Funds holding: 37 → 34 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
34
Holding in Top 10
2
Calls
$155K
Puts
$29K
Top Buyers
| 1 | +$93.2K | |
| 2 | +$80.7K | |
| 3 | +$76K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$75.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$50.2K |
Top Sellers
| 1 | -$643K | |
| 2 | -$469K | |
| 3 | -$185K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$124K |
| 5 |
ASGS
Alpha Square Group S
New York
|
-$104K |